Back to search

Article

Prognostic Biomarker MUC4 Mutations in Colon Adenocarcinoma Correlating with Tumor Microenvironment

2021-01-07

Abstract excerpt

<h4>Background: </h4> Immunotherapy is a new strategy for Colorectal cancer (CRC) treatment. Tumor mutation burden (TMB) may act as an emerging biomarker for predicting responses to immunotherapy. Nevertheless, no studies investigate if these gene mutations correlate to TMB and tumor-infiltrating immune cells. <h4>Methods: </h4>: Somatic mutation data for CRC samples were obtained from The Cancer Genome Atlas (TCG...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e06bfb3-9d2b-5bd8-81c9-d9adbaf98478
DOI
10.21203/rs.3.rs-137615/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic Biomarker MUC4 Mutations in Colon Adenocarcinoma Correlating with Tumor MicroenvironmentDOI 10.21203/rs.3.rs-137615/v1
Select a neighboring publication to make it the new centre.